sibutramine_hcl
/home/vnmr1/vnmrsys/data/sibutramine_hcl_d2o_Quant_001.fid
May 19 2011
Process macro: dea_sibutramine_D2O_maleic
Quantitation Method: NMR-maleic/D2O
Sibutramine HCl lot# 446981
Varian vnmrs 400 MHz NMR
DEA# 741514  Varian S/N MR0906W028
d2o with 0 ppm reference
sample weight: 7.342 mg
Internal Std: maleic (MW= 116.07, #H= 2), weight: 9.8520 mg
maleic acid lot 1394367 (Fluka)
volume: 1.0 mL
internal standard correction factor= 1.000

sibutramine HCl monohydrate  MW= 334.32

Integral result: 98.61 +/-0.23% (6 of 8 integrals)
Integral results:
7.49 ppm (4.0000H): 98.91%  *  
3.74 ppm (1.0000H): 98.44%  *  
2.87 ppm (3.0000H): 98.29%  *  
2.49 ppm (4.0000H): 100.06% (A) (D) correction factor= 0.9943
2.26 ppm (3.0000H): 98.55%  *  (D) correction factor= 0.9952
1.81 ppm (4.0000H): 99.82% (A) (D) correction factor= 0.9921
1.47 ppm (1.0000H): 98.71%  *  (D) correction factor= 0.9943
1.03 ppm (6.0000H): 98.79%  *  
LEGEND
 * :  used in reported result
(A):  result is a statistical outlier
(B):  Signal-to-Noise ratio <20
(D): C13 satellites of nearby peaks considered in
     final quantitation result using correction factor shown.
Median Absolute Deviation (MAD) value for integrals is 0.30%
MAD based on smallest S/N


Ratio of internal standard to 0 ppm reference peak: 5.681
